Stuttgart - Delayed Quote • EUR Laboratorios Farmaceuticos Rovi, S.A. (41L.SG) Follow Compare 65.30 +0.15 +(0.23%) At close: 8:02:51 AM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations 3 Stocks That May Be Priced Below Their Estimated Value In January 2025 As global markets navigate a mixed economic landscape marked by resilient labor markets and inflationary pressures, investors are closely monitoring the impact of these factors on stock valuations. With U.S. equities experiencing volatility and small-cap stocks underperforming, there is growing interest in identifying stocks that may currently be priced below their estimated value. In such an environment, a good stock often exhibits strong fundamentals, resilience to market fluctuations, and... Performance Overview Trailing total returns as of 1/31/2025, which may include dividends or other distributions. Benchmark is IBEX 35... Return 41L.SG IBEX 35... YTD +6.61% +7.21% 1-Year +5.43% +23.20% 3-Year +9.16% +43.66%